Montesinos Andres, Ardiaca Maria, Juan-Sallés Carles, Tesouro Miguel A
J Avian Med Surg. 2015 Mar;29(1):1-8. doi: 10.1647/2013-056.
In this study we evaluated the effects of meloxicam administered at 0.5 mg/kg IM q12h for 14 days on hematologic and plasma biochemical values and on kidney tissue in 11 healthy African grey parrots (Psittacus erithacus). Before treatment with meloxicam, blood samples were collected and renal biopsy samples were obtained from the cranial portion of the left kidney from each of the birds. On day 14 of treatment, a second blood sample and biopsy from the middle portion of the left kidney were obtained from each bird. All birds remained clinically normal throughout the study period. No significant differences were found between hematologic and plasma biochemical values before and after 14 days of treatment with meloxicam, except for a slight increase in median beta globulin and corresponding total globulin concentrations, and a slight decrease in median phosphorus concentration. Renal lesions were absent in 9 of 10 representative posttreatment biopsy samples. On the basis of these results, meloxicam administered at the dosage used in this study protocol does not appear to cause renal disease in African grey parrots.
在本研究中,我们评估了以0.5毫克/千克的剂量肌肉注射美洛昔康,每12小时一次,持续14天,对11只健康非洲灰鹦鹉(Psittacus erithacus)的血液学和血浆生化指标以及肾脏组织的影响。在用美洛昔康治疗前,采集了每只鸟的血液样本,并从左肾头部获取了肾脏活检样本。在治疗的第14天,从每只鸟的左肾中部获取了第二份血液样本和活检样本。在整个研究期间,所有鸟类临床状态均正常。在用美洛昔康治疗14天前后,血液学和血浆生化指标未发现显著差异,只是β球蛋白中位数和相应的总球蛋白浓度略有增加,磷中位数浓度略有下降。在10份代表性的治疗后活检样本中,有9份未出现肾脏病变。基于这些结果,按照本研究方案使用的剂量给予美洛昔康,似乎不会在非洲灰鹦鹉中引起肾脏疾病。